@serotinybio profile picture
Serotiny @serotinybio

Designing Therapeutic Genes for cell & gene therapies

Joined July 2016
  • Tweets 9
  • Following 32
  • Followers 67
Photos and videos
We're excited to announce our collaboration with @JanssenUS to identify novel CAR signaling domains for next generation cell therapies. @JNJInnovation businesswire.com/news/home/2…

Serotiny Announces a Research Collaboration With Janssen to Optimize Designs for Chimeric Antigen...

Serotiny, a leader in high-throughput therapeutic Multi-Domain Protein (tMDP) engineering, announced today a collaboration with Janssen Biotech, Inc., one of...

businesswire.com
1
Serotiny@serotinybio
23 May 2022
Serotiny welcomes Chad May as Chief Scientific Officer! businesswire.com/news/home/2…

Serotiny Appoints Chad May, Ph.D., as Chief Scientific Officer

Serotiny, a leader in high-throughput therapeutic Multi-Domain Protein (tMDP) engineering for the next generation of cell and gene therapies, has appointed C...

businesswire.com
1
Serotiny@serotinybio
28 Feb 2022
Serotiny and Tessera Therapeutics enter into collaboration to engineer and optimize programmable Gene Writer proteins. businesswire.com/news/home/2…

Serotiny and Tessera Therapeutics enter into collaboration to engineer and optimize programmable...

Serotiny, a leader in high-throughput therapeutic Multi-Domain Protein (tMDP) engineering, and Tessera Therapeutics, a biotechnology company pioneering a new...

businesswire.com
1
2
Serotiny retweeted
Brian Naughton@btnaughton
2 Jul 2018
Our friends at @serotinybio were just funded by @nanodimension and @8VC. And they are hiring! serotiny.bio/careers/ Check it out if you are into protein design, synbio, CAR-T, CRISPR etc. I believe their codebase is in @golang too!
3
4
Serotiny@serotinybio
19 Oct 2017
Congratulations, again! F.D.A. Approves Second Gene-Altering Treatment for Cancer nyti.ms/2zkXnib
Serotiny@serotinybio
13 Jul 2017
FDA unanimously recommends its first approval for a Chimeric Antigen Receptor. nyti.ms/2ua577M

F.D.A. Panel Recommends Approval for Gene-Altering Leukemia Treatment (Published 2017)

If accepted, which is likely, it will be the first gene therapy ever to reach the American market. “This is the beginning of something big,” a doctor said.

nytimes.com
We've released Pinecone - our synthetic protein design software! Design by function, buy DNA, stop cloning! serotiny.bio
Load more